A nationwide recall has been issued for the MAD300 nasal atomizer, the device used to administer the heroin overdose drug naxalone. The recall does not impact the medication, according to a release ...
Offers no-hassle, free virtual visit with healthcare provider for patients to receive neffy for $0 co-pay if eligible with commercial insurance ...
A New Drug Application (NDA) for CARDAMYST is currently being evaluated by the U.S. Food & Drug Administration (FDA) which has set a new Prescription Drug User Fee Act (PDFUA) target date of December ...
Q. On my last few trips, I developed severe nasal allergies and runny nose while on the plane. It was uncomfortable and embarrassing. Other travelers may have thought I had a bad cold or something ...
ENA Respiratory has raised US$22.4m (AU$34m) in Series B financing to support the phase 2 clinical development of its nasal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback